Genetics in Medicine’s (GIM) SARS-CoV-2/COVID-19 Published Articles and Resources
GIM’s goal is to ensure timely distribution of important SARS-CoV-2/COVID-19 research and commentaries by expediting review and publication of relevant accepted manuscripts. All articles related to COVID-19 published in the journal are freely available. Submit your research to GIM.
GenePod is the podcast from the journal Genetics in Medicine. Join us as host Cynthia Graber delves into the latest research in medical genetics and genomics, featuring content from this leading journal. Tune in here: iTunes, Google Podcasts, Overcast, RSS Feed, or SoundCloud.
July 2020
COVID-19 presents challenges for care of patients in genetics and metabolic disease clinics.
The COVID-19 pandemic is unprecedented and clinicians have faced correspondingly unprecedented challenges in caring for patients in genetics and metabolic disease clinics who require routine check-ups and ongoing treatments. Yet, in overcoming these challenges, doctors have identified a few boons to patient care that may continue to benefit patients in the long run. Listen in to this month’s GenePod to hear how Dr. Nicola Brunetti-Pierri, a clinician at the Federico II University Hospital in Naples, Italy, and Dr. Elaine Pereira, a clinical geneticist at Columbia University in New York City, two of the areas hardest hit by the pandemic, adapted patient care amid government lock-downs and what silver linings they found. Please see the related articles here and here. Download (.mp3).
June 2020
International collaborations aim to provide genetic clues to COVID-19’s variable disease path and outcomes.
In this month’s podcast, Genetics in Medicine reached out to members of the genetics research community involved in the global initiatives to identify the genes that cause differences in susceptibility and outcomes to COVID-19: Mark Daly, PhD, director for the Institute of Molecular Medicine Finland and a member of the Broad Institute in Massachusetts, Kári Stefánsson, MD, founder and CEO of deCODE, and our own Deputy Editor, David T. Miller, MD, PhD, a medical geneticist at Boston Children’s Hospital. Together, these three discuss key methods involved in conducting genome-wide studies on a global level to understand differences in SARS-CoV-2 infection rate and severity. The hope is, these efforts will be vital for providing clues to pathways of viral infection and ultimately development of therapeutics and vaccines. Download (.mp3)
